Skip to content

What is PerClot?: Understanding the Absorbable Hemostatic Powder

3 min read

In May 2023, the U.S. Food and Drug Administration (FDA) granted approval for the PerClot Absorbable Hemostatic System, introducing a plant-based hemostatic powder for surgical use. PerClot is an adjunct hemostat designed to assist surgeons in controlling bleeding that is mild to moderate when other conventional methods are ineffective or impractical.

Quick Summary

PerClot is a sterile, absorbable, polysaccharide powder derived from plant starch used in surgery to control capillary, venous, and small arteriolar bleeding. It works by rapidly absorbing water from the blood to create a gelled matrix, which accelerates the natural clotting cascade. The granules are biocompatible and are absorbed by the body over time.

Key Points

  • Polysaccharide Composition: PerClot is an absorbable hemostatic powder made from modified plant starch granules, making it biocompatible and free of human or animal components.

  • Rapid Hemostasis: It functions by rapidly absorbing water from blood, concentrating platelets and coagulation proteins to accelerate the natural clotting cascade.

  • Adjunctive Use: PerClot is primarily indicated as an adjunct to control mild to moderate capillary, venous, and arteriolar bleeding in various surgical procedures.

  • Avoid Intravascular Injection: A critical safety warning is never to inject PerClot into blood vessels, as it can cause potentially fatal thromboembolism.

  • Absorbable and Non-Pyrogenic: The powder is enzymatically degraded and absorbed by the body over several days, eliminating the need for removal after achieving hemostasis.

  • Delivery Options: The system includes standard and extended applicator tips, including a laparoscopic version for minimally invasive surgery.

In This Article

What is PerClot?

PerClot is a medical device consisting of absorbable polysaccharide granules made from purified plant starch. It serves as an adjunctive hemostatic agent to manage bleeding during surgery. Manufactured by Baxter International Inc., it is applied as a dry, sterile powder using an applicator system. The granules are biocompatible, non-pyrogenic, and free of human or animal components.

How PerClot Works to Control Bleeding

PerClot's mechanism relies on its ability to quickly absorb water from blood. This process concentrates clotting factors, platelets, and red blood cells, accelerating the body's natural clotting cascade. The granules swell, forming a gelled, adhesive matrix that acts as a mechanical barrier.

The body's enzymes degrade the granules, leading to absorption within about 96 hours, depending on usage and site. Its absorbable nature eliminates the need for removal.

Indications and Delivery

PerClot is indicated for various surgical procedures, such as cardiac, general, and urological surgeries, to manage capillary, venous, and small arteriolar bleeding. It is not recommended for neurological or ophthalmic procedures.

  • Open Surgical Procedures: Applied using a standard applicator tip.
  • Laparoscopic Procedures: Uses specialized 38cm laparoscopic tips.

Application process:

  1. Remove excess blood by blotting or suctioning.
  2. Apply dry powder to the bleeding area using a bellows applicator.
  3. Apply pressure with a non-adhering material until hemostasis.
  4. Irrigate and aspirate to remove any excess dry powder.

Safety, Warnings, and Adverse Events

PerClot is generally safe and effective, but requires adherence to warnings and precautions.

Contraindications and Warnings

  • Intravascular Injection: Strictly prohibited due to risk of life-threatening embolism.
  • Severe Bleeding: Not for treating severe arterial bleeding; use conventional methods.
  • Surgical Site: Use cautiously in contaminated areas.
  • Patient Sensitivity: Not studied in patients sensitive to starch.
  • Diabetic Patients: Limit use to 50g due to potential glucose load effects.

Potential Adverse Effects

Based on studies, potential issues include:

  • Increased inflammatory markers and fever.
  • Rare cases of infection and bowel obstruction, especially if residual powder is left.
  • Compression due to swelling if excess powder is not removed from confined areas.

Comparison with Other Hemostatic Agents

Feature PerClot Surgicel™ Fibrin Sealants Absorbable Gelatin Sponge
Composition Polysaccharide granules (plant-based) Oxidized Regenerated Cellulose (ORC) Human or animal fibrinogen and thrombin Purified porcine or bovine gelatin
Mechanism Rapidly absorbs water to concentrate clotting factors and forms a physical gel matrix Swells and converts to a gel to initiate clotting by forming a matrix Combines fibrinogen and thrombin to form a natural fibrin clot Provides a physical matrix for platelets and clotting factors to adhere to
Preparation Ready to use, no mixing required Ready to use, applied dry Often requires mixing and application via specialized systems Applied as a sponge, often with thrombin or saline
Efficacy Effective for mild to moderate bleeding; comparable to similar polysaccharide agents Highly effective; penetrates blood to reach bleeding source Very effective, especially for severe bleeding and large surfaces Effective, but may not be suitable for severe bleeding
Absorption Absorbed within ~96 hours Absorbed over weeks Absorbed over weeks Absorbed over weeks
Potential Risks Rare infection if not removed, swelling risk in confined spaces, contraindicated for intravascular use Possible nerve entrapment or foreign body reactions Risk of thrombosis if absorbed systemically; potential for transmitting infectious agents Foreign body reactions, potential for nerve damage with misuse
Handling Delivered as a powder via bellows and applicator tips Available as powder, knitted sheets, or fabrics Comes in specialized applicators, often a liquid or gel Sponge that can be cut to size

The Role of PerClot in Surgical Hemostasis

PerClot is important in surgical practice as a reliable, ready-to-use option for bleeding control. Its plant-based formulation is beneficial for patients with sensitivities. Studies, like the CLOT trial, show comparable safety and efficacy to alternatives for intraoperative bleeding in general, cardiac, and urological surgeries. Using hemostatic agents like PerClot can support blood management strategies, potentially reducing transfusions and complications.

Conclusion

PerClot is an effective, absorbable hemostatic powder from plant starch for managing mild to moderate surgical bleeding. Its mechanism, involving rapid water absorption and gel matrix formation, enhances natural clotting. Applied via a simple system, PerClot is a user-friendly solution for various procedures. Surgeons must follow warnings, especially regarding intravascular use and removing excess powder. The integration of such products reflects medical technology advancements aimed at improving patient care. For FDA approval details, refer to the official document.

Sources

: https://www.fda.gov/medical-devices/recently-approved-devices/perclot-polysaccharide-hemostatic-system-p210036

: https://www.accessdata.fda.gov/cdrh_docs/pdf21/P210036C.pdf

Frequently Asked Questions

PerClot is a sterile, absorbable hemostatic powder composed of modified polysaccharide granules derived from purified plant starch. It is biocompatible and contains no human or animal components.

PerClot works by rapidly absorbing water from the blood, which creates a concentrated mix of platelets, red blood cells, and clotting proteins. This accelerates the natural clotting process, while the powder forms an adhesive, gel-like matrix that provides a physical barrier to stop bleeding.

PerClot is used as an adjunctive hemostat in surgical procedures to assist in the control of mild to moderate capillary, venous, and small arteriolar bleeding. It is not for treating severe or life-threatening hemorrhage.

Yes, PerClot is an absorbable material. The granules are enzymatically degraded by the body and are absorbed within a matter of days, dependent on the amount applied and the surgical site.

PerClot is not indicated for all types of surgery. Specifically, its safety and effectiveness have not been established for neurological and ophthalmic procedures, and it should not be used in those specialties.

The most significant risk is potential embolism and death if the powder is injected into blood vessels. Other risks include tissue compression if excess powder is not removed from confined areas and potential infection in contaminated wounds.

The PerClot system utilizes a bellows applicator to dispense the powder. For open surgery, a standard applicator is used, while a 38cm laparoscopic tip is available for minimally invasive procedures.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.